Medtech in a Minute: Mergers, Collabs, and Recalls (Oh My)

Catch up on the latest medtech news from Medtronic, Second Sight, Masimo and others – in one minute or less.

Amanda Pedersen

September 2, 2022

2 Min Read
Medtech in a Minute.png

Second Time's a Charm for Second Sight

Second Sight Medical Products as the company has completed its merger with Nano Precision Medical and rebranded as Vivani Medical. The retinal prosthesis company was part of a failed merger with Pixium Vision last year.

Faulty HeartWare Batteries Continue to Plague Medtronic

A year after pulling its HeartWare Ventricular Assist Device (HVAD) System from the market, Medtronic is still dealing with regulatory issues associated with the device. The latest Medtronic recall relates to an increase in battery electrical faults due to an interaction between the HeartWare battery software and an internal component. This is the third recall associated with the HVAD System since the company discontinued it last year.

Wearables Space Heats Up

A new collaboration between Medtronic and BioIntelliSense, as well as Masimo's W1 launch, added some spice to the wearables space this week. Medtronic has agreed to distribute BioIntelliSense’s BioButton multi-parameter wearable designed for continuous, connected monitoring. Masimo announced a full market release of its W1 wrist-worn wearable for consumer use, and entered into a general launch phase for a medical version of the watch outside the United States. The medical version of Masimo W1 includes additional measurement capabilities including pot-check electrocardiogram (ECG), and atrial fibrillation (A-fib) detection.

And in case you missed our last Medtech in a Minute report...

GE Healthcare Leads AliveCor Funding Round

AliveCor plans to exend its reach to patients via a series F round led by GE Healthcare. NGK-NTK (through a CVC partnership with Pegasus Tech Ventures) joined the round, along with existing investors Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, and WP Global Partners. The company will use the new funds to introduce subscription services, KardiaCare and KardiaComplete for patients, payers, and employers, and KardiaPro for physicians. These subscription services are supported by the company's personal ECG devices, including KardiaMobile, KardiaMobile 6L, and KardiaMobile Card. This financing will also allow for continued advancements in AliveCor's AI roadmap and pipeline of innovations.

Levita Attracts $26M for Magnetic-Assisted Robotic Surgery

Levita Magnetics raised $26 million in a series C financing. A health tech investment group managed by investor Evan Norton led the round, with additional participation from MedTex Ventures, Invermaster, and Carao Ventures, among returning investors. The financing will be used to support the regulatory and short-term commercial efforts for its Magnetic-Assisted Robotic Surgery (MARS) platform.

The Future Looks Bright for CathVision

CathVision, a medical technology company developing electrophysiology (EP) solutions, raised $7.2 million in funding from existing investors. The funding is expected to help the company advance commercial operations for the ECGenius System and “support the continued development of artificial intelligence-powered analytic modules to provide electrophysiologists with unprecedented levels of automated analysis during cardiac ablation procedures.”

About the Author(s)

Amanda Pedersen

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals connect the dots between the medtech news of the day and the bigger picture. She has been covering the medtech industry since 2006.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like